These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 33165272)
1. Evaluating Ceftriaxone 80 mg/kg Administration by Rapid Intravenous Infusion-A Clinical Service Evaluation. Patel S; Green H; Gray J; Rutter M; Bevan A; Hand K; Jones CE; Faust SN Pediatr Infect Dis J; 2021 Feb; 40(2):128-129. PubMed ID: 33165272 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial. Ibrahim LF; Hopper SM; Orsini F; Daley AJ; Babl FE; Bryant PA Lancet Infect Dis; 2019 May; 19(5):477-486. PubMed ID: 30853250 [TBL] [Abstract][Full Text] [Related]
3. Ambulatory intravenous ceftriaxone in paediatric A&E: a useful alternative to hospital admission? Smith JK; Alexander S; Abrahamson E Emerg Med J; 2011 Oct; 28(10):877-81. PubMed ID: 21325012 [TBL] [Abstract][Full Text] [Related]
4. Intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis. Ibrahim LF; Huang L; Hopper SM; Dalziel K; Babl FE; Bryant PA Lancet Infect Dis; 2019 Oct; 19(10):1101-1108. PubMed ID: 31420292 [TBL] [Abstract][Full Text] [Related]
5. Evaluating an admission avoidance pathway for children in the emergency department: outpatient intravenous antibiotics for moderate/severe cellulitis. Ibrahim LF; Hopper SM; Connell TG; Daley AJ; Bryant PA; Babl FE Emerg Med J; 2017 Dec; 34(12):780-785. PubMed ID: 28978652 [TBL] [Abstract][Full Text] [Related]
6. Ceftriaxone-associated cholelithiasis: 30 min drip infusion versus bolus injection. Dinleyici EC; Bor O; Kebapci M; Aydogdu SD Pediatr Int; 2010 Dec; 52(6):890. PubMed ID: 21166949 [No Abstract] [Full Text] [Related]
7. Intramuscular ceftriaxone in comparison with oral amoxicillin-clavulanate for the treatment of acute otitis media in infants and children. Wang CY; Lu CY; Hsieh YC; Lee CY; Huang LM J Microbiol Immunol Infect; 2004 Feb; 37(1):57-62. PubMed ID: 15060689 [TBL] [Abstract][Full Text] [Related]
8. Cellulitis: Home Or Inpatient in Children from the Emergency Department (CHOICE): protocol for a randomised controlled trial. Ibrahim LF; Babl FE; Orsini F; Hopper SM; Bryant PA BMJ Open; 2016 Jan; 6(1):e009606. PubMed ID: 26754176 [TBL] [Abstract][Full Text] [Related]
9. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study. Roberts JA; Boots R; Rickard CM; Thomas P; Quinn J; Roberts DM; Richards B; Lipman J J Antimicrob Chemother; 2007 Feb; 59(2):285-91. PubMed ID: 17135183 [TBL] [Abstract][Full Text] [Related]
10. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability. Lode H; File TM; Mandell L; Ball P; Pypstra R; Thomas M; Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883 [TBL] [Abstract][Full Text] [Related]
11. A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia. Blumer JL; Ghonghadze T; Cannavino C; O'Neal T; Jandourek A; Friedland HD; Bradley JS Pediatr Infect Dis J; 2016 Jul; 35(7):760-6. PubMed ID: 27078119 [TBL] [Abstract][Full Text] [Related]
12. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Bradley JS; Wassel RT; Lee L; Nambiar S Pediatrics; 2009 Apr; 123(4):e609-13. PubMed ID: 19289450 [TBL] [Abstract][Full Text] [Related]
13. A pilot study evaluating the prescribing of ceftriaxone in hospitals in Ghana: findings and implications. Afriyie DK; Amponsah SK; Dogbey J; Agyekum K; Kesse S; Truter I; Meyer JC; Godman B Hosp Pract (1995); 2017 Oct; 45(4):143-149. PubMed ID: 28657382 [TBL] [Abstract][Full Text] [Related]
14. A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Cannavino CR; Nemeth A; Korczowski B; Bradley JS; O'Neal T; Jandourek A; Friedland HD; Kaplan SL Pediatr Infect Dis J; 2016 Jul; 35(7):752-9. PubMed ID: 27093162 [TBL] [Abstract][Full Text] [Related]
15. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre. Shalviri G; Yousefian S; Gholami K J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488 [TBL] [Abstract][Full Text] [Related]
16. The effects of ceftriaxone by intravenous push on adverse drug reactions in the emergency department. Agunbiade A; Routsolias JC; Rizvanolli L; Bleifuss W; Sundaresan S; Moskoff J Am J Emerg Med; 2021 May; 43():245-248. PubMed ID: 32291165 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of ceftriaxone utilization in medical and emergency wards of Tikur Anbessa specialized hospital: a prospective cross-sectional study. Sileshi A; Tenna A; Feyissa M; Shibeshi W BMC Pharmacol Toxicol; 2016 Feb; 17():7. PubMed ID: 26891697 [TBL] [Abstract][Full Text] [Related]
18. Ambulatory intravenous antibiotic therapy for children with preseptal cellulitis. Brugha RE; Abrahamson E Pediatr Emerg Care; 2012 Mar; 28(3):226-8. PubMed ID: 22344208 [TBL] [Abstract][Full Text] [Related]
19. Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis. Neuhaus TJ; Berger C; Buechner K; Parvex P; Bischoff G; Goetschel P; Husarik D; Willi U; Molinari L; Rudin C; Gervaix A; Hunziker U; Stocker S; Girardin E; Nadal D Eur J Pediatr; 2008 Sep; 167(9):1037-47. PubMed ID: 18074149 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic treatment for urinary tract infections in pediatric patients. Hellerstein S Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]